Liftstream is an executive search recruitment company in the life sciences sector
Wilson Therapeutics has announced that Andrew Kay has been appointed as Chairman of its Board of Directors. The company’s previous Chairman, Hugh Rienhoff, M.D. will continue to advise the company as a consultant.
Complix, a biopharmaceutical company focused on developing a pipeline of transformative protein therapeutics, called Alphabodies™, mainly focused on oncology and autoimmune diseases, today announced the appointment of Hans Schikan as Chairman of its Board of Directors.
Fresh from announcing that Hans Schikan, ex-CEO of Prosensa, would be joining the Board of Directors at Wilson Therapeutics, the company have announced the appointment of another Genzyme allumni, Dr. Carl Bjartmar as chief medical officer (CMO). Dr. Bjartmar will report to Jonas Hansson, chief executive officer, and will join the company’s management team.
Authored by James Sheppard